Year One Results Out for Value-Based Payment Modifier Program

Share this content:
Year One Results Out for Value-Based Payment Modifier Program
Year One Results Out for Value-Based Payment Modifier Program

MONDAY, Dec. 18, 2017 (HealthDay News) -- Almost 30 percent of eligible practices failed to register and report data in the first year of the Physician Value-Based Payment Modifier program, according to a report published in the December issue of Health Affairs.

Karen E. Joynt Maddox, M.D., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues examined performance and participation of physicians in the first year of Medicare's Physician Value-Based Payment Modifier program, launched in 2015. The program included practices with 100 or more physicians in the first year; 1,010 practices met this criterion.

The researchers found that 899 of the practices had at least one attributed beneficiary. Of these practices, 29.3 percent failed to report performance data and received a reporting-based penalty of 1 percent. Of the practices that reported performance data, better performance on quality and costs was seen for those that elected quality tiering (voluntarily received performance-based penalties or bonuses) and for those with high use of electronic health records, compared with other practices. The quality was better, and costs similar, for practices with a primary care focus versus other practices.

"These findings translated into differences in the receipt of penalties and bonuses and may have implications for performance patterns under the Merit-based Incentive Payment System," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

E. Coli Found in Water at Tennessee Ziplining Facility

<i>E. Coli</i> Found in Water at Tennessee Ziplining ...

One visitor to the CLIMB Works Zipline Canopy Tour in Gatlinburg tested positive for norovirus and E. coli

FDA: Illnesses Tied to Fresh Crab Meat Imported From Venezuela

FDA: Illnesses Tied to Fresh Crab Meat Imported ...

Illnesses appear to be caused by Vibrio parahaemolyticus bacteria

FDA Approves First Drug to Treat Smallpox

FDA Approves First Drug to Treat Smallpox

New treatment offers additional option should smallpox ever be used as a bioweapon

is free, fast, and customized just for you!




Already a member?

Sign In Now »